Tag: chronic pain

September 28, 2018
May 10, 2018

Phivida Corporate Update for Fiscal Q2 2018

Phivida [“fiii-vee-daa”] Holdings Inc (CSE:VIDA) is pleased to provide a corporate update for the second quarter of fiscal 2018.
May 2, 2018

Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the U.S. Patent and Trademark Office ("USPTO") issued...
May 1, 2018

Phivida Appoints New Chief Commercial Officer

Phivida Holdings Inc (CSE:VIDA) is pleased to announce the appointment of Mr. Douglas Campbell as The Company's new Chief Commercial...
May 1, 2018

Kalytera Reports 2017 Financial Results

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today reported financial results for the year-ended December 31, 2017. (All...
April 30, 2018

Key Stock Catalysts in the FDA Drug Application Process

Pharmaceutical and biotech companies in the US must follow a standard process to advance a new drug candidate through nonclinical...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.